A Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long-Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence
✍ Scribed by Bankole A. Johnson; Nassima Ait-Daoud; Henri-Jean Aubin; Wim van den Brink; Richard Guzzetta; John Loewy; Bernard Silverman; Elliot Ehrich
- Book ID
- 110086744
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 243 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0145-6008
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr
## Abstract Tolcapone is a potent, reversible catechol‐O‐methyltransferase (COMT) inhibitor with both peripheral and central activity. It has been demonstrated to improve motor function and allow levodopa dose reductions in Parkinson's disease (PD) patients who are experiencing either a stable resp